## Big Pharma influnces doctors by funding medical schools  # 

Big Pharma needs doctors to power the machine that generates their profit. Only one-third ($26 billion) of their annual $85 billion profit comes from over-the-counter drugs that patients can buy without a prescription‚Äîand so Pharma has to keep doctors prescribing. The best way to do that? Control the medical school curriculum. And how to do that? Pay for stuff.

Individual datapoints for American medical schools are harder to come by, but we know what‚Äôs going on with our Canadian friends north of the border. Canadian pharmaceutical company Apotex gave the University of Toronto CAN$2,875,077 over one decade for research projects, GlaxoSmithKline contributed CAN$4,566,930 over two decades, Janssen donated CAN$1,642,998 over five years, Allergan gave CAN$272,696 over two years, and Bristol Myers Squibb sponsored the salaries of two physician-scientists. We can only assume that American medical schools are reading from the same script.

And it‚Äôs in the university‚Äôs best interest to maintain these industry relationships, for two reasons: 1) direct drug money as above; and also 2) potential drug money for in-house discoveries. Congressional passage of the Bayh-Dole Act of 1980 gave universities the right to patent any discoveries stemming from federally funded research, to own that IP, and then to license those discoveries to Big Pharma in return for institutional royalties.

___

##### References

- Lustig, Robert. (2021). [[Metabolical Chapter 6. Because Big Pharma Was Their Teacher]] (p. 122). New York, NY: _HarperCollins Publishers_.

##### Metadata

Type: #üî¥ 
Tags: [[Medicine]]
Status: #‚òÄÔ∏è 